At PhaseBio, we are determined to overcome the lack of new treatment options for serious cardiovascular diseases and provide superior outcomes for patients and the healthcare system. We are driven by high-quality science, and we leverage our team’s deep expertise to rapidly develop a pipeline of unique medicines.